Home > Resources > Company Profiles > eResearch Technology, Incorporated

eResearch Technology, Incorporated (ERES)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Dr. Michael J. McKelvey, Ph.D. , CEO/President/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Dr. Michael J. McKelvey, Ph.D., CEO/President/Director

30 South 17th Street

Philadelphia, PA 19103

US Map it

Phone: (215) 972-0420

Fax: (215) 972-0414

www.ert.com



Overview

The Company provides technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently.

Employees

Number of Employees: 339
Revenue per Employee: $276,043

Top Executives

Robert S. Brown, Senior VP, Divisional
Dr. Joel Morganroth, M.D., Chairman of the Board/Chief Scientific Officer/Director
Thomas P. Devine, Executive VP/Other Executive Officer

Keith D. Schneck, Executive VP/CFO/Secretary
David Laky, Senior VP, Divisional
Amy Furlong, Executive VP, Divisional

Gregory Sadowski, Senior VP, Divisional
Dr. Jeffrey S. Litwin, M.D., Executive VP/Chief Medical Officer
George Tiger, Senior VP, Divisional

John M. Blakeley, Executive VP, Divisional
Steven M. Eisenstein, Vice President/Secretary

Board of Directors

Dr. Joel Morganroth, M.D., Chairman of the Board/Chief Scientific Officer/Director
Stephen M. Scheppmann, Director
Keith D. Schneck, Executive VP/CFO/Secretary

Steven M. Eisenstein, Vice President/Secretary
Michael DeMane, Director
Stephen S. Phillips, Director

Sheldon M. Bonovitz, Director
John H. Park, Director

Financials

Quarterly
Annual

Income Statement 08/2008 05/2008 02/2008 11/2007
Sales 11.02 Mil. 11.64 Mil. 9.64 Mil. 8.54 Mil.
Gross Operating Profit 24.45 Mil. 22.04 Mil. 19.27 Mil. 15.43 Mil.
Operating Income before D & A (EBITDA) 14.99 Mil. 12.84 Mil. 11.61 Mil. 9.29 Mil.
Total Income Before Interest Expenses (EBIT) 11 Mil. 8.92 Mil. 8.05 Mil. 5.94 Mil.
Total Net Income 6.66 Mil. 5.75 Mil. 5.16 Mil. 3.71 Mil.
Basic EPS, Total 0.13 0.11 0.1 0.07
Diluted EPS, Total 0.13 0.11 0.1 0.07

BALANCE STATEMENT 08/2008 05/2008 02/2008 11/2007
Cash and Equivalents 49.45 Mil. 40.57 Mil. 38.08 Mil. 27.2 Mil.
Total Assets 90.34 Mil. 79.92 Mil. 78.33 Mil. 97.86 Mil.
Total Liabilities 28.05 Mil. 26.2 Mil. 32.96 Mil. 22.48 Mil.
Total Capitalization 129.2 Mil. 120.03 Mil. 113.51 Mil. 108.01 Mil.

Cash Flow 08/2008 05/2008 02/2008 11/2007
Net Cash From Continuing Operations 17.98 Mil. 7.6 Mil. 36 Mil. 22.72 Mil.
Net Cash From Investing Activities -7.64 Mil. -4.65 Mil. -13.33 Mil. -11.56 Mil.
Net Cash From Financing Activities 1.02 Mil. -459 K. -89 K. 266 K.
Net Change in Cash & Cash Equivalents 11.36 Mil. 2.49 Mil. 22.58 Mil. 11.7 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 33.5 Mil. 33.28 Mil. 28 Mil. 27.57 Mil.
Gross Operating Profit 65.19 Mil. 53.08 Mil. 58.85 Mil. 81.82 Mil.
Operating Income before D & A (EBITDA) 37.38 Mil. 23.22 Mil. 34.18 Mil. 58.24 Mil.
Total Income Before Interest Expenses (EBIT) 24.46 Mil. 13.22 Mil. 24.37 Mil. 50.22 Mil.
Total Net Income 15.25 Mil. 8.31 Mil. 15.36 Mil. 29.72 Mil.
Basic EPS, Total 0.3 0.17 0.31 0.58
Diluted EPS, Total 0.29 0.16 0.29 0.54

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 38.08 Mil. 15.5 Mil. 18.43 Mil. 45.81 Mil.
Total Assets 78.33 Mil. 81.27 Mil. 70.55 Mil. 87.39 Mil.
Total Liabilities 32.96 Mil. 19.95 Mil. 24.75 Mil. 29.48 Mil.
Total Capitalization 113.51 Mil. 93.62 Mil. 79.97 Mil. 86.85 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations 36 Mil. 16.33 Mil. 26.19 Mil. 59.62 Mil.
Net Cash From Investing Activities -13.33 Mil. -20.95 Mil. -29.78 Mil. -26.74 Mil.
Net Cash From Financing Activities -89 K. 1.3 Mil. -23.57 Mil. -25.58 Mil.
Net Change in Cash & Cash Equivalents 22.58 Mil. -2.94 Mil. -27.37 Mil. 7.44 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
Alliance Imaging, Incorporated
517.32 Mil.
Genoptix, Incorporated
545.94 Mil.
Bio-Reference Laboratories, Inc.
372.48 Mil.
Enzo Biochem, Inc.
364.99 Mil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented